Carnitine prices in China registered a modest increase in the first half of July 2025, following a sharp rise in June driven by tightening inventories, reduced production due to seasonal shutdowns, and strong global demand. Export activity remained firm amid currency-related cost pressures, while downstream sectors like pharmaceuticals and nutraceuticals sustained robust offtake. Prices are expected to rise further in the second half of July due to persistent international demand and limited supply.
Carnitine prices in the Chinese market stabilized with a slight bullish drift in the first half of July 2025 on the back of the strong rise in June. High demand abroad and a shrinking supply environment, brought on both by planned reductions in production and seasonal changes in operations, is driving the consistent upward trend. The market still presents a picture of bullishness since consumers work around an increase in prices and limited supplies.
The Carnitine prices in China have increased dramatically in June 2025 owing to a few major supply side and macroeconomic factors. Low inventory forces tightened because a number of manufacturers started planning their annual summer shutdowns of maintenance, which reduced their output shortening supplies. Although such reduction was not that drastic, it brought about a state of scarcity which manufacturers exploited through higher prices. Better trade conditions and a significant increase in new domestic orders also contributed to upward pressure on Carnitine producers. The market was further aided by government policies to revive the momentum in the economy and enhance domestic consumption.
Also, the deterioration of the US Dollar against the Chinese Yuan throughout the month negatively affected the profitability of exports, stimulating suppliers to raise the prices of Carnitine in order to protect margins. This currency situation supported the necessity of price increase, especially at the volumes that are to be exported. Consequently, the manufacturers intended to transfer these expenses to consumers, increasing the inflationary pressure in Carnitine price on the domestic, as well as export markets.
In terms of the demand, Carnitine sales were increasing strongly in June 2025. Market demand by major downstream applications, such as in pharmaceuticals and nutraceuticals, continued to be strong with downstream consumers continuing to maintain steady purchasing behavior. Good logistics and steady industrial output were helping to maintain domestic demand. Meanwhile, western awareness of Chinese Carnitine soared with increasing demand out of North America, and Europe, and Southeast Asia. These consumers, looked to Chinese suppliers which increased the global competition and increased export demand for Chinese Carnitine.
Exporters also reported increasing contract enquiries and sales confirmations through June, evidence of a revived confidence in the market and supporting the optimistic view on Carnitine. Short-term inventory building was observed at the distribution level due to the high buying levels, as many buyers placed order to protect against future price increments. Nevertheless, the imbalance in the supply and demand element persisted and lent solidity to the prices in the market.
Market experts have predicted further increase in Carnitine price in China during the second half of July. Increasing demand internationally is expected to stimulate sustained price growth with international buyers still heavily relying on Chinese suppliers to fulfill their sourcing requirements. Moreover, some production plants undergo a summer maintenance downtime, which could lead to additional restriction of supply levels within the nearest weeks. All these dynamics which include increasing worldwide offtake, and declining production capacity are also expected to continue driving Carnitine prices higher in the rest of the month.
